When it comes to biotech stocks, the ultimate goal is always to get a drug to market. Acrux today shared the good news that their testosterone topic solution has been approved by the US Food & Drug Administration (FDA)...
Another day, another biotech winner. The Acrux Ltd [ASX:ACR] share price is up 33.33% at time of writing. Surging on the back of confirmation of a new deal in the US. They’ve joined forces with private company TruPharma...
